| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 03/17/2004 | EP0946590B1 Dihydroxypropyl cysteine peptide and agent containing this peptide |
| 03/17/2004 | CN1482137A Novel method for abstracting vitriol capreomycin |
| 03/17/2004 | CN1142178C Novel peptides and remedy for bone diseases contg. same as active ingredient |
| 03/17/2004 | CN1142177C Isolated MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof |
| 03/16/2004 | US6706862 Backbone-cyclized BPI peptidomimetics |
| 03/16/2004 | US6706254 Cyanine dye bioconjugates useful for diagnostic imaging and therapy |
| 03/16/2004 | US6706192 Subjecting cyclosporin complex to multistep silica gel column chromatography in which the mobile phase is a solvent comprising toluene as the main component |
| 03/11/2004 | WO2004020999A1 Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer |
| 03/11/2004 | WO2004020579A2 Method of humanizing immune system molecules |
| 03/11/2004 | WO2004020466A1 Protein tyrosine phosphatase inhibitors |
| 03/11/2004 | WO2004020462A1 Cxcr4 antagonist and use thereof |
| 03/11/2004 | WO2004020461A1 A group of novel synthetic antibiotic peptides |
| 03/11/2004 | WO2004020454A2 Modified transferrin fusion proteins comprising duplicate transferrin amino or carboxy terminal domains |
| 03/11/2004 | WO2004020405A2 Modified transferrin fusion proteins |
| 03/11/2004 | WO2004019983A1 Method of degrading transcriptional factors of saccharometabolism-associated gene, method of inhibiting the degradation and degradation inhibitor |
| 03/11/2004 | WO2003071268A3 Method for discovering pharmacologically active substances |
| 03/11/2004 | WO2003059943A3 Conformation-specific, protein kinase binding peptides and related methods and products |
| 03/11/2004 | WO2003046572A3 Biopolymer markers predictive of alzheimers disease |
| 03/11/2004 | WO2003042247A3 Modified anti-tnf alpha antibody |
| 03/11/2004 | WO2003040172A3 Methods and reagents for peptide-bir interaction screens |
| 03/11/2004 | WO2003034071A3 A method of forming a dynamic combinatorial library using a scaffold |
| 03/11/2004 | WO2003029288A3 Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same |
| 03/11/2004 | WO2003020213A3 Methods and compositions for treating inflammatory disorders |
| 03/11/2004 | WO2003018618A3 Catalysis of the cis/trans isomerisation of secondary amide peptide compounds |
| 03/11/2004 | WO2003004646A3 Genetic analysis of peyers's patches and m cells and methods and compositions targeting peyer's patches and m cell receptors |
| 03/11/2004 | US20040049011 Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome |
| 03/11/2004 | US20040048801 Use of activity-dependent neurotrophic factor-derived polypeptides for enhancing learning and memory:pre-and post-natal administration |
| 03/11/2004 | US20040048798 Especially CTL polypeptides of specific sequences |
| 03/11/2004 | US20040048790 Inducing cellular immune responses to p53 using peptide and nucleic acid compositions |
| 03/11/2004 | US20040048353 Helicobacter pylori proteins useful for vaccines and diagnostics |
| 03/11/2004 | US20040048347 The oligomers may be provided to ruminants as bioavailable amino acid supplements that are resistant to degradation in the rumen |
| 03/11/2004 | US20040048243 Identifying peptides by obtaining a sample, exposing it to a phage display library recovering bound substances; use in gene therapy vectors and in diagnosis and treatment of cancer |
| 03/11/2004 | US20040047880 Component for vaccine |
| 03/11/2004 | DE10240894A1 Verstärkung der Resorption von Subtanzen über die Haut und Schleimhaut Enhance the absorption of Subtanzen through the skin and mucous membrane |
| 03/11/2004 | DE10238697A1 New peptaibol peptide compounds having high alpha-aminoisobutyric acid content, useful for treating neurological diseases such as schizophrenia, obtained by culturing Trichoderma strain |
| 03/11/2004 | CA2537158A1 Cxcr4 antagonist and use thereof |
| 03/11/2004 | CA2496938A1 Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer |
| 03/11/2004 | CA2496772A1 Protein tyrosine phosphatase inhibitors |
| 03/11/2004 | CA2496745A1 Method of degrading transcriptional factors of saccharometabolism-associated gene, method of inhibiting the degradation and degradation inhibitor |
| 03/11/2004 | CA2495210A1 Modified transferrin fusion proteins |
| 03/10/2004 | EP1396539A1 Human-type anti-blood coagulation factor viii antibody |
| 03/10/2004 | EP1395584A1 Uronium and immonium salts for peptide coupling |
| 03/10/2004 | EP1395275A2 Beta-secretase substrates and uses thereof |
| 03/10/2004 | EP0918547B1 Radiolabeled annexins |
| 03/10/2004 | EP0885011B1 Diagnosis of autoimmune diseases of the inner ear based on the detection of myelin protein p zero |
| 03/10/2004 | CN1481389A Process for synthesis of peptide having tryptophan residue |
| 03/10/2004 | CN1141317C Cyelosporin derivatives with anti-HIV effect |
| 03/09/2004 | US6703488 Use for intracellular delivery of drugs or other agents for diagnosis and therapy of malignancies or immune-mediated or inflammatory conditions providing rapid, efficient internal-ization of the cytokine receptor antibody/antigen complexes |
| 03/09/2004 | US6703367 Luteinizing hormone releasing hormone (lhrh) antagonist is administered to patient in menopause |
| 03/09/2004 | US6703362 Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods |
| 03/09/2004 | CA2216423C Ternary radiopharmaceutical complexes |
| 03/04/2004 | WO2004018997A2 Methods and compositions for modulating amyloid beta |
| 03/04/2004 | WO2004018706A2 A genomic approach to identification of novel broad-spectrum antimicrobial peptides from bony fish |
| 03/04/2004 | WO2004018670A1 Inhibitor of physiological activity of annexin 5 |
| 03/04/2004 | WO2004018644A2 HETEROGENEOUS FOLDAMERS CONTAINING α, β, AND/OR Ϝ-AMINO ACIDS |
| 03/04/2004 | WO2004018628A2 Charged peptide-amphiphile solutions & self-assembled peptide nanofiber networks formed therefrom |
| 03/04/2004 | WO2004018519A2 Therapeutic uses of monoclonal antibodies to the angiotensin-ii type-1 receptor |
| 03/04/2004 | WO2004018503A1 Template-fixed peptidomimetics with antibacterial activity |
| 03/04/2004 | WO2004018502A1 Compounds binding to p-selectin |
| 03/04/2004 | WO2004018498A2 Minicell display and products therefrom |
| 03/04/2004 | WO2003070755A3 Compounds, compositions and method for transporting cyclosporin molecules through the blood brain barrier |
| 03/04/2004 | WO2003052122A3 Gp41 inhibitor |
| 03/04/2004 | WO2003044054A3 Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases |
| 03/04/2004 | WO2003017924A3 Lipopeptide stereoisomers, methods for preparing same, and useful intermediates |
| 03/04/2004 | WO2002014352A9 Therapeutic compounds for ovarian cancer |
| 03/04/2004 | US20040043937 Antiinflammatory agents; osteoporosis; thrombosis; grafting of organs |
| 03/04/2004 | US20040043936 Antiproliferative and antiviral proteins and peptides |
| 03/04/2004 | US20040043472 Novel substances k97-0239 and process for producing the same |
| 03/04/2004 | US20040043463 Comprises inhibitory fusion protein topical for treating aberration affecting hair pigmentation, skin pigmentation and/or skin conditioning |
| 03/04/2004 | CA2746000A1 Biomarkers for diagnosing alzheimer's disease |
| 03/04/2004 | CA2745569A1 Biomarkers for diagnosing alzheimer`s disease |
| 03/04/2004 | CA2496422A1 Therapeutic uses of monoclonal antibodies to the angiotensin-ii type-1 receptor |
| 03/04/2004 | CA2496215A1 Template-fixed peptidomimetics with antibacterial activity |
| 03/04/2004 | CA2495794A1 A genomic approach to identification of novel broad-spectrum antimicrobial peptides from bony fish |
| 03/04/2004 | CA2493471A1 Compounds binding to p-selectin |
| 03/03/2004 | EP1394548A2 Method for serotyping using type-specific antigens |
| 03/03/2004 | EP1394255A2 NANBV diagnostics and vaccines |
| 03/03/2004 | EP1394180A1 Synthetic mimetic molecules of physiological binding molecules |
| 03/03/2004 | EP1394178A1 Peptide fragments of myelin basic protein, their pharmaceutical compositions and their use in treating multiple sclerosis |
| 03/03/2004 | EP1394177A1 High density lipoprotein-reactive peptides |
| 03/03/2004 | EP1392731A2 Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity |
| 03/03/2004 | EP1392729A2 Use of a peptide which activates guanylate-cyclase c for the treatment of respiratory airway problems via the airways, medicament, inhalation devices and method of diagnosis |
| 03/03/2004 | EP1392722A2 Echinocandin process |
| 03/03/2004 | EP1392721A1 Peptides and their use as inhibitors of hepatitis c virus ns3 protease |
| 03/03/2004 | EP1392347A2 Method of preventing cell death using segments of neural thread proteins |
| 03/03/2004 | EP1392345A2 Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis |
| 03/03/2004 | EP1392342A1 Global analysis of protein activities using proteome chips |
| 03/03/2004 | EP1392279A1 Trimethyl lock based tetrapartate prodrugs |
| 03/03/2004 | EP1196440B1 Therapeutic peptides derived from subsequences of bpi |
| 03/03/2004 | EP1011716B9 Neuromedin b receptor antagonists |
| 03/03/2004 | EP0797447B1 Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides |
| 03/03/2004 | EP0636028B1 Self-assembling polynucleotide delivery system comprising an amphiphatic cationic peptide |
| 03/03/2004 | EP0613375B1 Pharmaceutical lysine-containing polypeptide compositions and the use thereof |
| 03/03/2004 | CN1479788A Lactic acid bacteria capable of reducing indvidual's tendency to develop allergic reactions |
| 03/03/2004 | CN1478543A Therapeutic use of bactericidal/permeability improving protein product |
| 03/03/2004 | CN1140536C Minotopes and anti-mimotopes of human platelet glycoprotein Ib/Ix |
| 03/02/2004 | US6699869 β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins |
| 03/02/2004 | US6699835 Formulation of boronic acid compounds |
| 03/02/2004 | US6699673 Peptide for use in detection of methylated proteins |
| 03/02/2004 | US6699481 Peptides for inhibition of herpes simplex virus entry |